ClinicalTrials.Veeva

Menu

Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients

A

Assiut University

Status

Completed

Conditions

Critical Care

Treatments

Other: Neutrophil Lymphocyte Ratio

Study type

Observational

Funder types

Other

Identifiers

NCT02749487
IRB00009905

Details and patient eligibility

About

Neutrophil lymphocyte ratio NLR is an important index that evaluate the inflammatory status . It is a cost effective and readily available , and simply calculated , so that why investigators try to use it as a predictor of short term survival in the critically ill patients

Full description

NLR will be used as predictor for short term survival and patients stay in ICU in 2 groups of patients . Investigators will use it in a group of Medical Critically ill patients as respiratory failure , neuromuscular disorders , renal impairment . the other group is the critically ill surgical patients , as patients with multiple trauma , post major surgery

Enrollment

80 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Critically ill trauma patients

Exclusion criteria

  • auto immune disease endocrine disease renal dysfunction hepatic dysfunction malignancy smoking

Trial design

80 participants in 2 patient groups

cured (c)
Description:
Neutrophil Lymphocyte and platelet lymphocyte ratios as Predictors of Outcome in Traumatic Critically ill Patients
Treatment:
Other: Neutrophil Lymphocyte Ratio
Died ( M)
Description:
Neutrophil Lymphocyte and platelet lymphocyte ratios as Predictors of Outcome in Traumatic Critically ill Patients
Treatment:
Other: Neutrophil Lymphocyte Ratio

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems